D'AMBROSI, NADIA
 Distribuzione geografica
Continente #
NA - Nord America 9.191
AS - Asia 1.812
EU - Europa 1.488
SA - Sud America 295
Continente sconosciuto - Info sul continente non disponibili 261
AF - Africa 45
OC - Oceania 13
Totale 13.105
Nazione #
US - Stati Uniti d'America 9.104
SG - Singapore 800
IT - Italia 348
CN - Cina 325
RU - Federazione Russa 269
BR - Brasile 241
HK - Hong Kong 216
DE - Germania 171
VN - Vietnam 145
IE - Irlanda 116
SE - Svezia 101
GB - Regno Unito 96
UA - Ucraina 90
JP - Giappone 84
BD - Bangladesh 70
FR - Francia 68
FI - Finlandia 63
CA - Canada 57
PL - Polonia 48
IN - India 40
NL - Olanda 29
KR - Corea 27
ES - Italia 23
ID - Indonesia 22
AR - Argentina 17
CZ - Repubblica Ceca 16
IQ - Iraq 15
EC - Ecuador 12
TR - Turchia 12
ZA - Sudafrica 12
MX - Messico 11
AU - Australia 10
CI - Costa d'Avorio 10
PK - Pakistan 9
IL - Israele 8
JM - Giamaica 7
AT - Austria 6
CO - Colombia 6
EG - Egitto 6
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
GR - Grecia 5
LT - Lituania 5
PT - Portogallo 5
VE - Venezuela 5
BE - Belgio 4
DK - Danimarca 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
CL - Cile 2
GT - Guatemala 2
HR - Croazia 2
MN - Mongolia 2
MU - Mauritius 2
NP - Nepal 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 12.845
Città #
Woodbridge 1.993
Houston 1.655
Wilmington 1.622
Singapore 480
Fairfield 402
Ashburn 396
San Jose 318
Hong Kong 215
Chandler 191
Ann Arbor 187
Seattle 179
Beijing 134
Cambridge 127
Council Bluffs 117
Rome 111
Dublin 110
New York 102
Santa Clara 88
Los Angeles 85
Medford 83
Jacksonville 82
The Dalles 80
Munich 64
Tokyo 61
Ho Chi Minh City 46
Buffalo 45
Dallas 41
Lawrence 40
Dearborn 39
Moscow 39
Hanoi 36
Helsinki 29
Lauterbourg 29
Kraków 27
São Paulo 26
London 22
Denver 21
Milan 20
Falls Church 19
San Diego 18
Montreal 16
Toronto 16
Warsaw 16
Brooklyn 15
Chicago 15
Phoenix 15
Pune 15
North Bergen 14
San Francisco 14
Atlanta 13
Frankfurt am Main 13
Mülheim 12
Orem 12
Poplar 12
Turku 12
Amsterdam 11
Brno 11
Jakarta 11
Abidjan 10
Charlotte 10
Nuremberg 10
Salt Lake City 10
Stockholm 10
Columbia 9
Menlo Park 9
Mountain View 9
Norwalk 9
Shenzhen 9
Boston 8
Brasília 8
Johannesburg 8
Ankara 7
Miami 7
Naples 7
Redondo Beach 7
Seoul 7
Amagasaki 6
City of London 6
Lappeenranta 6
Leeds 6
Newark 6
Pittsburgh 6
Rio de Janeiro 6
San Mateo 6
St Louis 6
Zibo 6
Asunción 5
Belo Horizonte 5
Boardman 5
Bologna 5
Campinas 5
Chennai 5
Columbus 5
Da Nang 5
Del Norte 5
Haiphong 5
Manchester 5
Ottawa 5
Piscataway 5
Portland 5
Totale 9.906
Nome #
Copper at synapse: Release, binding and modulation of neurotransmission 524
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 493
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 488
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. 483
ALS: focus on purinergic signalling 466
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 466
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue 460
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis 456
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 438
Pathways to mitochondrial dysfunction in ALS pathogenesis 437
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 436
The S100B story: from biomarker to active factor in neural injury 429
P2 receptor modulation and cytotoxic function in cultured CNS neurons 413
Differences in the neurotoxicity profile induced by ATP and ATP gamma S in cultured cerebellar granule neurons 402
The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells 378
Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators 368
Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists 345
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation 313
Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells 260
UsnRNP trafficking is regulated by stress granules and compromised by mutant ALS proteins 216
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis 211
Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis 179
Ablation of p2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis 167
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation 166
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches 162
Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis 161
Commentary: multifactoriality of amytrophic lateral sclerosis: linking unfolded proteins to oxidative stress in microglia 155
Purinergic signaling: A common pathway for neural and mesenchymal stem cell maintenance and differentiation 148
Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis 145
The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93AModels, and Its Inhibition Decreases the Expression of Proinflammatory Genes 139
COntribution of S100A4-regulated pathways to inflammation in ALS models 123
Lipid catabolism and mitochondrial uncoupling are stimulated in brown adipose tissue of amyotrophic lateral sclerosis mouse models 123
UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor 114
Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism 112
Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models 105
Cytoplasmic accumulation of a splice variant of hnRNPA2/B1 contributes to FUS-associated toxicity in a mouse model of ALS 104
Fibrotic Scar in Neurodegenerative Diseases 101
N-acetylaspartate mitigates pro-inflammatory responses in microglial cells by intersecting lipid metabolism and acetylation processes. 97
Purinergic signalling at the plasma membrane: A multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis 96
Loss of homeostatic functions in microglia from a murine model of Friedreich's ataxia 88
Fibrosis as a common trait in amyotrophic lateral sclerosis tissues 88
Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells 87
The Contribution of Non-Neuronal Cells in Neurodegeneration: From Molecular Pathogenesis to Therapeutic Challenges 87
The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells 86
Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems 85
Extracellular ATP and neurodegeneration 82
S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System 80
P2 receptor web: complexity and fine-tuning 79
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models 78
C9orf72 Toxic Species Affect ArfGAP-1 Function 77
Niclosamide Targets Inflammatory and Profibrotic Pathways in Amyotrophic Lateral Sclerosis 76
Receptor webs: can the chunking theory tell us more about it? 72
Targeting S100A4 to study the macrophages-muscle cells cross-talk in models of Duchenne Muscular Dystrophy 70
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia 66
Metabotropic purinergic receptors in lipid membrane microdomains 66
CYTOPLASMIC AGGREGATION OF WT TDP-43 AND FUS P525L CAUSES GENOME DAMAGE IN A CELLULAR MODEL SYSTEM OF ALS 65
P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death 65
Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors 64
Targeting S100A4 to improve inflammation and fibrosis in Duchenne Muscular Dystrophy 64
Neuroinflammation in Friedreich's Ataxia 64
Do ATP and NO interact in the CNS? 60
Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones 60
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells 59
Protein cooperation: from neurons to networks 58
Inflammation in the CNS and PNS: From Molecular Basis to Therapy 54
Niclosamide reprograms macrophages and improves muscle integrity in Duchenne muscular dystrophy models 51
Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation 50
Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters 49
Repurposing niclosamide for the treatment of neurological disorders 47
Biochemical dissection of STAT3 signaling in amyotrophic lateral sclerosis 45
Repurposing niclosamide to target inflammatory and fibrotic pathways to affect ALS 30
Targeting S100A4 to modulate inflammation and improve muscle regeneration in Duchenne muscular dystrophy 28
PATHOGENIC FUS PROMOTES THE EXPRESSION OF AGGREGATION-PRONE SPLICING ISOFORMS OF HNRNPA2B1 IN AMYOTROPHIC LATERAL SCLEROSIS 23
Niclosamide ameliorates disease progression in models of amyotrophic lateral sclerosis 23
Totale 13.105
Categoria #
all - tutte 43.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 0 14 21 17 43 22 11 54 25 28 118
2022/2023579 45 42 8 55 57 120 46 26 60 2 33 85
2023/2024267 29 7 22 11 47 90 15 3 5 8 7 23
2024/20251.395 55 296 132 94 12 117 162 56 80 85 127 179
2025/20263.039 261 135 302 323 246 118 330 388 329 274 201 132
2026/2027518 258 116 144 0 0 0 0 0 0 0 0 0
Totale 13.105